• News
  • Inquiry
  • Contact Us for business opportunity
  • Recruitment information
  • Japanese
  • HOME
  • Vision
    Vision
    Introducing the vision SymBio Pharmaceuticals.
    • CEO message
      CEO message
    • SymBio in 2 minutes
      SymBio in 2 minutes
    • Corporate culture
      Corporate culture
    • Charter of Corporate Behavior
      Charter of Corporate Behavior
    • Book introduction
      Book introduction
  • Business model
    Business model
    I would like to introduce the business model of SymBio Pharmaceuticals.
    • Business domain and profit model
      Business domain and profit model
    • Proprietary drug discovery business
      Proprietary drug discovery business
    • Global business
      Global business
    • Joint research with academia
      Joint research with academia
    • Key person interview
      Key person interview
  • Pipeline
    Pipeline
    We would like to introduce the pipeline of SymBio Pharmaceuticals.
    • Pipeline overview
      Pipeline overview
    • SyB V-1901
      SyB V-1901
    • SyB L-0501
      SyB L-0501
  • IR information
    IR information
    Aiming for patient-centered, mutually supportive relationships among scientists, doctors, governments, and shareholders.
    • Latest IR information
      Latest IR information
    • IR news
      IR news
    • CEO message
      CEO message
    • Financial highlights
    • IR library
    • Analyst report
    • Video library
    • IR Calendar
    • General Meeting of Shareholders Information
    • Basic stock information
    • Electronic public notice
  • About SymBio
    About SymBio
    Company Information of SymBio Pharmaceuticals
    • Company Profile
      Company Profile
    • Origin of company name
      Origin of company name
    • History
      History
    • Officer introduction
    • Organization chart
    • Corporate
      governance
    • Compliance
      about
    • on transparency
      Information disclosure
    • SDGs initiatives
  • News
  • Inquiry
  • Recruitment of new drug information
  • Recruitment information
  • Japanese
  1. TOP
  2. IR information
  3. Latest IR information

Latest IR information

IR News

IR News
2025.05.08Earnings Report
Summary of Consolidated Financial Statements for the First Three Months of Fiscal Year Ending December 31, 2025 [Japanese GAAP]
2025.04.21Timely disclosure
Notice regarding the Issuance of Stock Acquisition Rights(Stock Options) to the Company’s Directors
2025.04.21Timely disclosure
Notice regarding the Issuance of Stock Acquisition Rights (Stock Options) to the Company’s Employees
2025.04.21IR Materials
訂正臨時報告書 (Japanese only)
2025.04.18IR Materials
訂正臨時報告書 (Japanese only)

IR materials

Batch download of the latest IR materials (Zip file)
事業計画及び成長可能性に関する事項 (Japanese Only)
Summary of Financial Results
決算説明会資料(2024年12月期) (Japanese Only)
株主通信 (Japanese Only)
有価証券報告書(第19期) (Japanese Only)
第18期株主総会資料 (Japanese Only)
四半期報告書(第20期第1四半期) (Japanese Only)

Video content

第20期定時株主総会 動画 (Japanese Only)
2024年12月期決算説明会 (Japanese Only)
動画で見るシンバイオ製薬 (Japanese Only)

Other content

SymBio in 2 minutes
IR library
Analyst report

IR information

  • Latest IR information
  • IR news
  • CEO message
  • Financial highlights
  • IR library
  • Analyst report
  • Video library
  • IR Calendar
  • General Meeting of Shareholders Information
  • Basic stock information
  • Electronic public notice
  • シェアード・リサーチ
SymBio Pharmaceuticals
  • Inquiry
  • Contact Us for business opportunity
  • Personal information protection policy, etc.
  • Privacy Notice for Clinical Trials in UK
  • About the use of the site
  • site map
Copyright © SymBio Pharmaceuticals Limited. All rights reserved.